UK markets close in 7 hours 26 minutes

Centessa Pharmaceuticals plc (CNTA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
9.46+0.06 (+0.64%)
At close: 04:00PM EDT
9.46 0.00 (0.00%)
After hours: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2020
Total revenue
6,853
6,853
0
0
Operating expenses
Research development
124,405
124,405
155,083
9,301
Selling general and administrative
53,731
53,731
55,200
1,139
Total operating expenses
178,136
178,136
210,283
10,440
Operating income or loss
-171,283
-171,283
-210,283
-10,440
Interest expense
9,906
9,906
7,277
378
Total other income/expenses net
-5,428
-5,428
362
155
Income before tax
-176,141
-176,141
-216,954
-10,663
Income tax expense
-25,056
-25,056
-747
-
Income from continuing operations
-151,085
-151,085
-216,207
-10,663
Net income
-151,085
-151,085
-216,207
-10,663
Net income available to common shareholders
-151,085
-151,085
-216,207
-10,663
Basic EPS
-0.15
-1.57
-2.31
-0.15
Diluted EPS
-0.15
-1.57
-2.31
-0.15
Basic average shares
70,891
96,178
93,401
70,891
Diluted average shares
70,891
96,178
93,401
70,891